JP2008534568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008534568A5 JP2008534568A5 JP2008503608A JP2008503608A JP2008534568A5 JP 2008534568 A5 JP2008534568 A5 JP 2008534568A5 JP 2008503608 A JP2008503608 A JP 2008503608A JP 2008503608 A JP2008503608 A JP 2008503608A JP 2008534568 A5 JP2008534568 A5 JP 2008534568A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disorder
- dihydro
- alkyl
- piperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](CNCC1)N1c1nc([C@](CC2)OC(*)*)c2cc1 Chemical compound C[C@](CNCC1)N1c1nc([C@](CC2)OC(*)*)c2cc1 0.000 description 8
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66718405P | 2005-03-31 | 2005-03-31 | |
| US76215906P | 2006-01-26 | 2006-01-26 | |
| PCT/IB2006/000655 WO2006103511A1 (en) | 2005-03-31 | 2006-03-21 | Cyclopentapyridine and tetrahydroquinoline derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008534568A JP2008534568A (ja) | 2008-08-28 |
| JP2008534568A5 true JP2008534568A5 (cg-RX-API-DMAC7.html) | 2008-10-09 |
| JP4318744B2 JP4318744B2 (ja) | 2009-08-26 |
Family
ID=36218589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503608A Expired - Fee Related JP4318744B2 (ja) | 2005-03-31 | 2006-03-21 | シクロペンタピリジンおよびテトラヒドロキノリン誘導体 |
Country Status (24)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005063712A1 (en) | 2003-12-23 | 2005-07-14 | Myogen, Inc. | 5-ht2 receptors modulators, their pharmaceuticals compositions and their use for the treatment of cardiovascular and muscle diseases |
| EP1844792A4 (en) * | 2004-12-14 | 2008-05-21 | Shionogi & Co | THERAPEUTIC AGENT AGAINST OBSTIPATION |
| WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
| EP2044029B1 (en) * | 2006-07-14 | 2011-01-26 | Pfizer Products Inc. | Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| CA2666193A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
| WO2008068157A1 (en) | 2006-12-07 | 2008-06-12 | F. Hoffmann-La Roche Ag | 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
| KR20100109978A (ko) | 2008-03-07 | 2010-10-11 | 에프. 호프만-라 로슈 아게 | 2-아미노퀴놀린 유도체 |
| SG176464A1 (en) * | 2008-05-09 | 2011-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| AR072707A1 (es) | 2008-07-09 | 2010-09-15 | Sanofi Aventis | Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| AU2010288523A1 (en) | 2009-08-26 | 2012-03-15 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| JO3250B1 (ar) | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
| WO2011071136A1 (ja) | 2009-12-11 | 2011-06-16 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| US8674218B2 (en) | 2010-12-15 | 2014-03-18 | General Electric Company | Restraint system for an energy storage device |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
| CN110236526B (zh) * | 2019-06-28 | 2022-01-28 | 李秋 | 基于咀嚼吞咽动作及心电活动的摄食行为分析和检测方法 |
| WO2024026423A1 (en) * | 2022-07-27 | 2024-02-01 | Black Diamond Therapeutics, Inc. | Substituted quinoline derivatives as pi3k inhibitors |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01211581A (ja) | 1988-02-18 | 1989-08-24 | Meiji Seika Kaisha Ltd | シクロペンテノピリジン誘導体および抗潰瘍剤 |
| US4985352A (en) | 1988-02-29 | 1991-01-15 | The Trustees Of Columbia University In The City Of New York | DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof |
| EP0361489A3 (en) | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | Novel 3,4-diaminoquinoline and pyridine compounds |
| ES2058630T3 (es) | 1989-03-03 | 1994-11-01 | Dainippon Pharmaceutical Co | Derivados de 2-(1-piperazinil)-4-fenilcicloalcanopiridinas, procedimientos de preparacion y composiciones farmaceuticas que los contienen. |
| JP2660086B2 (ja) | 1990-07-03 | 1997-10-08 | 明治製菓株式会社 | 脳及び心機能障害改善剤 |
| JPH04103572A (ja) | 1990-08-20 | 1992-04-06 | Dainippon Pharmaceut Co Ltd | ４―フェニル―２―（１―ピペラジニル）ピリジン誘導体 |
| EP0572863A1 (de) | 1992-06-05 | 1993-12-08 | F. Hoffmann-La Roche Ag | ZNS Pyrazinoindole |
| DE4326151A1 (de) | 1993-08-04 | 1995-02-09 | Hoechst Ag | Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen |
| TW334423B (en) | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
| TW270114B (cg-RX-API-DMAC7.html) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| US5698766A (en) | 1995-04-05 | 1997-12-16 | The Regents Of The University Of California | Transgenic animal model for testing drugs for treating eating disorders and epilepsy |
| TW477787B (en) | 1996-08-27 | 2002-03-01 | Pfizer | Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same |
| AU5343298A (en) | 1997-01-13 | 1998-08-03 | Yamanouchi Pharmaceutical Co., Ltd. | 5-ht2c receptor agonists and aminoalkylindazole derivatives |
| EP0863136B1 (en) | 1997-02-25 | 2003-09-24 | Akzo Nobel N.V. | Derivatives of azetidine and pyrrolidine |
| US6322738B1 (en) | 1997-07-24 | 2001-11-27 | Husky Injection Molding Systems Ltd. | Method of injection over-molding articles |
| US6040448A (en) | 1997-10-24 | 2000-03-21 | Neurogen Corporation | Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands |
| AU9810498A (en) | 1997-10-24 | 1999-05-17 | Neurogen Corporation | 1-(2-naphthyl) and 1-(2-azanaphthyl)-4 -(1-phenylmethyl)piperazines being dopamine d4 receptor subtyp e ligands |
| WO1999058490A2 (en) | 1998-05-08 | 1999-11-18 | Akzo Nobel N.V. | Novel aryl-hydro naphthalenal kanamines |
| GB9819035D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Res Ltd | Chemical compounds VII |
| JP2002523451A (ja) | 1998-09-01 | 2002-07-30 | ブリストル−マイヤーズ スクイブ カンパニー | カリウムチャネル抑制剤および方法 |
| GB9819019D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
| GB9819020D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds III |
| GB9819033D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
| JP2000191533A (ja) | 1998-10-19 | 2000-07-11 | Eisai Co Ltd | 鎮痛剤 |
| AU1738900A (en) | 1998-11-19 | 2000-06-05 | Nortran Pharmaceuticals Inc. | Serotonin ligands as pro-erectile compounds |
| EP1149085A1 (en) | 1999-01-27 | 2001-10-31 | Eli Lilly And Company | Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists |
| ES2252004T3 (es) | 1999-05-21 | 2006-05-16 | Biovitrum Ab | Nuevos compuestos, su uso y preparacion. |
| AU2001279056A1 (en) * | 2000-07-28 | 2002-02-13 | Goodrich Corporation | Optical waveguides and methods for making the same |
| CA2448729A1 (en) | 2000-11-20 | 2002-05-23 | Biovitrum Ab | Piperazinyl and piperidyl substituted heterocyclic compounds |
| SE0004245D0 (sv) * | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| TWI245761B (en) | 2001-03-01 | 2005-12-21 | Telik Inc | Antagonists of MCP-1 function and methods of use thereof |
| DK1385823T3 (da) | 2001-04-09 | 2007-03-26 | Novartis Vaccines & Diagnostic | Guanidinoforbindelser som melanocortin-4-receptor- (MC4-R) -agonister |
| US6825198B2 (en) | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| AU2004229404B2 (en) | 2003-04-11 | 2008-01-10 | Taigen Biotechnology | Aminoquinoline compounds |
| US7101881B2 (en) | 2003-06-11 | 2006-09-05 | Pfizer Inc | Tetrahydroquinolines |
| TW200612918A (en) | 2004-07-29 | 2006-05-01 | Threshold Pharmaceuticals Inc | Lonidamine analogs |
-
2006
- 2006-03-21 CA CA2602348A patent/CA2602348C/en not_active Expired - Fee Related
- 2006-03-21 KR KR1020077022374A patent/KR100894006B1/ko not_active Expired - Fee Related
- 2006-03-21 BR BRPI0609268-3A patent/BRPI0609268A2/pt not_active IP Right Cessation
- 2006-03-21 AP AP2007004144A patent/AP2007004144A0/xx unknown
- 2006-03-21 MX MX2007012082A patent/MX2007012082A/es active IP Right Grant
- 2006-03-21 WO PCT/IB2006/000655 patent/WO2006103511A1/en not_active Ceased
- 2006-03-21 NZ NZ560917A patent/NZ560917A/en not_active IP Right Cessation
- 2006-03-21 EP EP06710585A patent/EP1869000A1/en not_active Withdrawn
- 2006-03-21 AU AU2006228378A patent/AU2006228378A1/en not_active Abandoned
- 2006-03-21 EA EA200701853A patent/EA200701853A1/ru unknown
- 2006-03-21 JP JP2008503608A patent/JP4318744B2/ja not_active Expired - Fee Related
- 2006-03-28 PE PE2006000343A patent/PE20061333A1/es not_active Application Discontinuation
- 2006-03-29 GT GT200600128A patent/GT200600128A/es unknown
- 2006-03-29 AR ARP060101218A patent/AR054021A1/es unknown
- 2006-03-30 NL NL1031473A patent/NL1031473C2/nl not_active IP Right Cessation
- 2006-03-30 DO DO2006000076A patent/DOP2006000076A/es unknown
- 2006-03-30 UY UY29446A patent/UY29446A1/es not_active Application Discontinuation
- 2006-03-30 TW TW095111125A patent/TW200722423A/zh unknown
- 2006-03-31 US US11/395,327 patent/US7507732B2/en not_active Expired - Fee Related
-
2007
- 2007-08-23 IL IL185492A patent/IL185492A0/en unknown
- 2007-08-27 NO NO20074368A patent/NO20074368L/no not_active Application Discontinuation
- 2007-09-19 CR CR9386A patent/CR9386A/es not_active Application Discontinuation
- 2007-09-28 MA MA30262A patent/MA29354B1/fr unknown
- 2007-09-28 TN TNP2007000367A patent/TNSN07367A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008534568A5 (cg-RX-API-DMAC7.html) | ||
| CA2602348A1 (en) | Cyclopentapyridine and tetrahydroquinoline derivatives | |
| JP6982376B2 (ja) | Ｒｏｒガンマ調節物質としての置換型テトラヒドロキノリン化合物 | |
| JP5522371B2 (ja) | 化合物とその製造方法、および医薬組成物 | |
| Ohashi et al. | Discovery of the investigational drug TAK-441, a pyrrolo [3, 2-c] pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility | |
| AU2022217791A9 (en) | Tricyclic-amido-bicyclic prmt5 inhibitors | |
| CA2870000C (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
| JP2008044931A5 (cg-RX-API-DMAC7.html) | ||
| JP2011526294A5 (cg-RX-API-DMAC7.html) | ||
| CN105143190B (zh) | 作为mao抑制剂的被取代的萘啶和喹啉化合物 | |
| JP2012526735A5 (cg-RX-API-DMAC7.html) | ||
| CA2785923A1 (en) | Therapeutic compounds and related methods of use | |
| JP2010520264A5 (cg-RX-API-DMAC7.html) | ||
| TW200524928A (en) | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases | |
| TW201014849A (en) | 1,2-disubstituted heterocyclic compounds | |
| CN101268073A (zh) | 杂环化合物、制备方法及其用途 | |
| JP6992109B2 (ja) | ｍＧｌｕＲ２陰性アロステリック調節剤としてのクロマン、イソクロマン及びジヒドロイソベンゾフラン誘導体、組成物、及びそれらの使用 | |
| JP2012526736A5 (cg-RX-API-DMAC7.html) | ||
| KR920003981B1 (ko) | 디아제핀 항알레르기 화합물 | |
| CN105722840B (zh) | 作为PI3K、mTOR抑制剂的稠合喹啉化合物 | |
| JP2012530129A5 (cg-RX-API-DMAC7.html) | ||
| JP2007510649A5 (cg-RX-API-DMAC7.html) | ||
| KR20150119370A (ko) | Cns 장애 및 다른 장애의 치료를 위한 pde4 동종효소의 억제제로서의 아자벤즈이미다졸 화합물 | |
| JP2003516989A (ja) | Ｇａｂａ受容体リガンドとしてのピラゾロ−ピリジン誘導体 | |
| CN1458933A (zh) | 噻吩并嘧啶化合物及其盐以及其制备方法 |